Login

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer 2024 pay Source
Amy L. Burroughs
Chief Executive Officer
Title from the Form 4 dated May 5, 2026
$8,240,502
Andrew Gengos
Chief Financial Officer
Title from the Form 4 dated May 5, 2026
Not reported
Emil Kuriakose
Chief Medical Officer
Title from the Form 4 dated May 5, 2026
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 29, 2025 · updated by the 8-K of May 5, 2026

Directors
4
serving now
Average tenure
5.0 years
from year joined
Director Age On board Committees Other public boards Source
Hongbo Lu
54 2020
5 years
Nominating and Corporate Governance Committee
RiboX Therapeutics Ltd., Visirna Therapeutics (Suzhou) Co., Ltd., Zenas BioPharma, Inc.
Jon Filderman Joined May 5, 2026
- - - -
Melissa Leonard Joined May 5, 2026
- - - -
Dalton Smart Joined May 5, 2026
- - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 29, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support